These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 21306831)

  • 1. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
    Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
    Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
    Gold MS; Badgaiyan RD; Blum K
    Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug abuse relapse rates linked to level of education: can we repair hypodopaminergic-induced cognitive decline with nutrient therapy?
    Blum K; Schoenthaler SJ; Oscar-Berman M; Giordano J; Madigan MA; Braverman ER; Han D
    Phys Sportsmed; 2014 May; 42(2):130-45. PubMed ID: 24875980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addiction and brain reward and antireward pathways.
    Gardner EL
    Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
    Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
    J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
    Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
    Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
    Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M
    Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.
    Fried L; Modestino EJ; Siwicki D; Lott L; Thanos PK; Baron D; Badgaiyan RD; Ponce JV; Giordano J; Downs WB; Gondré-Lewis MC; Bruce S; Braverman ER; Boyett B; Blum K
    Curr Pharm Biotechnol; 2020; 21(6):528-541. PubMed ID: 31820688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
    Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
    Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
    Brabant C; Alleva L; Quertemont E; Tirelli E
    Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural substrates of drug craving and relapse in drug addiction.
    Self DW
    Ann Med; 1998 Aug; 30(4):379-89. PubMed ID: 9783837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
    Crunelle CL; Miller ML; Booij J; van den Brink W
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):69-79. PubMed ID: 19959340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and drug addiction: the nucleus accumbens shell connection.
    Di Chiara G; Bassareo V; Fenu S; De Luca MA; Spina L; Cadoni C; Acquas E; Carboni E; Valentini V; Lecca D
    Neuropharmacology; 2004; 47 Suppl 1():227-41. PubMed ID: 15464140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of addiction.
    Clay SW; Allen J; Parran T
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.